Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system

Quadrivalent influenza vaccines (QIVs) are designed to prevent influenza disease caused by two influenza A viruses (H1N1 and H3N2) and both influenza B lineages. Risk-monitoring of QIVs to identify adverse events (AEs) is necessary as influenza vaccines are reformulated each year. We developed a new...

Descripció completa

Dades bibliogràfiques

Autors principals:	Miguel Betancourt-Cravioto, Patricia Cervantes-Powell, Roberto Tapia-Conyer, Shaleesa Ledlie, Sonja Gandhi-Banga
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2022-01-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	influenza vaccines vaccination safety post-marketing safety surveillance seasonal influenza risk management plan adverse events pharmacovigilance immunization
Accés en línia:	http://dx.doi.org/10.1080/21645515.2021.1935170
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!